NCT01306175View on ClinicalTrials.gov

Drug Interaction Study of Digoxin and BI 10773

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

Digoxin plus BI 10773

Digoxin 0.5 mg as single dose, BI 10773 medium dose once daily

DRUG

Digoxin

Digoxin 0.5 mg as single dose

Trial Locations (1)

Unknown

1245.40.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY